Cyxone Employee Directory
Biotechnology ResearchSkåne, Sweden11-50 Employees
Cyxone AB is a clinical biotechnology company focused on developing immunomodulatory therapies for autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. Headquartered in Malmö in the Skåne region of Sweden, the firm aims to address unmet needs by pursuing medicines that could be safer and more effective for patients with autoimmune conditions. Its development portfolio includes rabeximod in a Phase II program for rheumatoid arthritis and T20K, which has completed a Phase I infusion study for multiple sclerosis. With a relatively small team, Cyxone sits in the biotechnology research space, pursuing clinical-stage programs that advance candidates through early-phase trials. In the clinical development landscape, the company focuses on autoimmune disease therapies.